MARKET

PGEN

PGEN

Precigen Inc
NASDAQ
8.56
+0.51
+6.34%
After Hours: 8.66 +0.1 +1.17% 19:59 09/30 EDT
OPEN
8.13
PREV CLOSE
8.05
HIGH
8.98
LOW
8.09
VOLUME
11.69M
TURNOVER
--
52 WEEK HIGH
8.98
52 WEEK LOW
2.990
MARKET CAP
3.06B
P/E (TTM)
-7.7861
1D
5D
1M
3M
1Y
5Y
1D
Precigen: The FDA's Platform Technology Designation And The Institutional Crossover Effect
Seeking Alpha · 8h ago
Learn Why The Bull Case For Precigen (PGEN) Could Change Following FDA Platform Designation
Simply Wall St · 9h ago
Weekly Report: what happened at PGEN last week (0921-0925)?
Weekly Report · 2d ago
Precigen (PGEN) Gains FDA Platform Backing As Its Valuation Story Gets Harder To Ignore
Simply Wall St · 3d ago
Dollar General, Stitch Fix, PubMatic, Precigen, Stem trending
TipRanks · 4d ago
B. Riley Securities Initiates Coverage of Precigen at Buy
NASDAQ · 5d ago
This Tower Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Benzinga · 5d ago
Is Precigen (PGEN) Above Fair Value After The FDA Platform Nod?
Simply Wall St · 5d ago
More
About PGEN
Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company developing gene and cell therapies for improving outcomes for patients with unmet medical needs. The Company’s proprietary technology platforms develop product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company’s segments include Biopharmaceuticals and Exemplar. The Biopharmaceuticals segment is primarily comprised of the Company's legal entities as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. The Exemplar is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar, its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Webull offers Precigen Inc stock information, including NASDAQ: PGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGEN stock methods without spending real money on the virtual paper trading platform.